Myriad Genetics, Inc. (MYGN) — Analyst estimates
Consensus analyst estimates for Myriad Genetics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 231.6M | 0.12 | 1 |
| 2027 | 240.64M | 0.1 | 1 |
| 2028 | 248.93M | 0.04 | 2 |
| 2029 | 1.08B | 0.57 | 1 |
| 2030 | 1.10B | 0.64 | 1 |
Consensus analyst estimates by fiscal year.